19:08:27 EDT Mon 21 Sep 2026
Enter Symbol
or Name
USA
CA



Grey Wolf Health Corp.
Symbol WOLF
Shares Issued 34,640,294
Close 2026-09-21 C$ 1.70
Market Cap C$ 58,888,500
Recent Sedar+ Documents

ORIGINAL: GREY WOLF HEALTH TO PRESENT AT THE SMALLCAP DISCOVERIES 2026 INVESTOR CONFERENCE

2026-09-21 16:30 ET - News Release

GREY WOLF HEALTH TO PRESENT AT THE SMALLCAP DISCOVERIES 2026 INVESTOR CONFERENCE

Canada NewsWire

TORONTO, Sept. 21, 2026 /CNW/ -- Grey Wolf Health Corp. (TSXV: WOLF) ("Grey Wolf" or the "Company"), a Canadian diversified health company, today announced that Angela Cechetto, CEO, is scheduled to present a corporate update at the Smallcap Discoveries 2026 Investor Conference on Tuesday September 29, 2026 at 1:30pm PT in Vancouver, British Columbia.

Ms. Cechetto will also be available for one-on-one meetings in Vancouver, British Columbia on September 28-29, 2026. Investors interested in meeting with Grey Wolf during that time should contact the conference coordinator or email investors@greywolfah.com.

About Smallcap Discoveries 

Smallcap Discoveries is Canada's leading small-cap investment community, dedicated to uncovering high-quality, under-followed companies with strong growth potential. Founded and led by veteran investors, the platform provides in-depth research, exclusive insights, and direct access to emerging opportunities in the micro and small-cap space. Through its premium membership, conferences, and educational resources, Smallcap Discoveries connects growth-focused investors with exceptional companies, helping members identify tomorrow's leaders today.

To learn more about Smallcap Discoveries, visit our website at www.smallcapdiscoveries.com.

About Grey Wolf Health Corp.

Grey Wolf Health Corp., headquartered in Toronto, Canada, is a diversified health ‎company focused on bringing to market a broad portfolio of products that meets the ‎unmet needs of veterinarians, physicians and patients. The Company's strategy is to in-license, acquire or compound prescription and non-prescription products for commercialization in the animal and human health market ‎in Canada. For additional information, please visit: www.greywolfah.com.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

Forward Looking Statements

This news release includes certain statements that may be deemed "forward-looking statements." All statements in this new release, other than statements of historical facts, that address events or developments that the Company expects to occur, are forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," "potential," and similar expressions, or that events or conditions "will," "would," "may," "could," or "should" occur. Forward-looking information in this news release includes statements related to the Company's attendance at the Smallcap Discoveries 2026 Investor Conference.Forward-looking statements are based on the beliefs, estimates and opinions of the Company's management on the date the statements are made. Except as required by applicable securities laws, the Company undertakes no obligation to update these forward-looking statements in the event that management's beliefs, estimates or opinions, or other factors, should change.

SOURCE Grey Wolf Health Corp.

Cision View original content: http://www.newswire.ca/en/releases/archive/September2026/21/c9242.html

Contact:

For further information, please contact:‎ Angela Cechetto, Chief Executive Officer, E-mail: investors@greywolfah.com

© 2026 Canjex Publishing Ltd. All rights reserved.